Form 4: Amphastar Pharmaceuticals Executive Sells Shares

Sentiment:

Insider Transaction (Form 4)


William J Peters, CFO, EVP & TREASURER and a Director of Amphastar Pharmaceuticals, Inc., sold 8,180 shares of common stock on August 7, 2026 for $22.48 per share.

Summary

  • Option exercise/conversion: acquired 5,053 Common Stock at $19.79 ($99,999) on August 7, 2026; holds 181,026 after (Direct).
  • Open-market sale: disposed of 8,180 Common Stock at $22.48 ($183,886) on August 7, 2026; holds 172,846 after (Direct).
  • Option exercise/conversion: disposed of 5,053 Employee Stock Option (right to buy) on August 7, 2026 (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $183,886 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.

Insider Transactions

William J Peters — Director, Officer (CFO, EVP & TREASURER)

Transaction made under a Rule 10b5-1 trading plan.

DateTransactionSecuritySharesPriceValueHeld After
2026-08-07Option exercise/conversionCommon Stock5,053$20$100.0K181,026
2026-08-07Open-market saleCommon Stock8,180$22$183.9K172,846
2026-08-07Option exercise/conversionEmployee Stock Option (right to buy)5,053——0

Key Dates

DateDescription
2026-08-07Option exercise/conversion (5,053 shares)
2026-08-07Open-market sale (8,180 shares)
2026-08-07Option exercise/conversion (5,053 shares)

Keywords

insider transaction, Form 4, AMPH, Amphastar Pharmaceuticals, Inc., bearish, William J Peters

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.